Organisation paid for research Program year 2025 Source: CMS Open Payments

Focal Point Vision

Neither a doctor nor a teaching hospital

Research payments

$417,990

66 payments

Through program year 2025, Focal Point Vision is reported as receiving $417,990 in research payments, across 66 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$17,960	4
2024	Research	$127,813	34
2023	Research	$42,490	12
2022	Research	$120,935	9
2020	Research	$24,645	3
2019	Research	$84,147	4

Breakdown

Who paid Research payments · program years 2019–2025

RxSight Inc $309,198 59 payments
Avedro Inc. $82,745 1 payment
Glaukos Corporation $24,645 3 payments
Allergan Inc. $1,402 3 payments

Studies the money was for Research payments · program years 2019–2025

RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $120,935 9 payments
308 $82,745 1 payment
Pmcs-010 $70,000 1 payment
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $63,453 35 payments
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $42,490 12 payments
A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus $24,645 3 payments
Csp-1003 $12,320 2 payments
Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension $1,402 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.